A Nanotechnology-Based In Vivo Gene Delivery Platform Allowing the In Vivo Targeting & Transduction of T-Cells for Haematological Malignancies & Beyond

Time: 1:30 pm
day: Day 1 – Track A – Afternoon

Details:

  • Presentation of the gene delivery platform
  • In vitro and in vivo safety and efficacy data
  • Towards clinics

Speakers: